Vera Therapeutics (VERA) Non Operating Income (2020 - 2026)

Vera Therapeutics has reported Non Operating Income for 7 years, with the latest figure at $4.1 million in Q1 2026.

• For the quarter ending Q1 2026, Non Operating Income fell 25.45% year-over-year to $4.1 million; the trailing twelve-month figure through Mar 2026 stood at $14.5 million (down 18.74% YoY), and the FY2025 full-year result was $15.9 million, up 5.56% from the prior year.
• Non Operating Income for Q1 2026 stood at $4.1 million, up from $3.1 million in the prior quarter.
• The five-year high for Non Operating Income was $5.5 million in Q1 2025, with the low at -$64000.0 in Q1 2022.
• Historically, Non Operating Income has averaged $2.5 million across 5 years, with a median of $2.7 million in 2024.
• Annual changes were most pronounced in 2022 — Non Operating Income sank 3300.0% — and 2023, when it jumped 1957.81%.
• Vera Therapeutics' Non Operating Income stood at $1.1 million in 2022, then grew by 20.21% to $1.4 million in 2023, then jumped by 299.56% to $5.5 million in 2024, then sank by 43.35% to $3.1 million in 2025, then jumped by 31.83% to $4.1 million in 2026.
• The last three Non Operating Income figures came in at $4.1 million (Q1 2026), $3.1 million (Q4 2025), and $3.6 million (Q3 2025), per Business Quant data.